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Abstract
Background—Specimen labeling errors have long plagued the laboratory industry putting 
patients at risk of transfusion-related death, medication errors, misdiagnosis, and patient 
mismanagement. Many interventions have been implemented and deemed to be effective in 
reducing sample error rates. The objective of this review was to identify and evaluate the 
effectiveness of laboratory practices/ interventions to develop evidence based recommendations 
for the best laboratory practices to reduce labeling errors.
Content—The standardized LMBP™ A-6 methods were used to conduct this systematic review. 
Total evidence included 12 studies published during the time periods of 1980 to September 2015. 
Combined data from seven studies found that the interventions developed as a result of improved 
communication and collaboration between the laboratory and clinical staff resulted in substantial 
decrease in specimen labeling errors (Median relative percent change in labeling errors: −75.86; 
IQI: −84.77, −58.00). Further data from subset of four studies showed a significant decrease in 
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specimen labeling errors after the institution of the standardized specimen labeling protocols 
(Median relative percent decrease in specimen labeling errors: −72.45; IQI: −83.25, −46.50).
Summary—Based on the evidence included in this review, the interventions that enhance the 
communication and collaboration between laboratory and healthcare professionals can decrease 
the specimen identification errors in healthcare settings. However, more research is needed to 
make the conclusion on the effectiveness of other evaluated practices in this review including 
training and education of the specimen collection staff, audit and feedback of labeling errors, and 
implementation of new technology (other than barcoding).
INTRODUCTION
Sample labeling errors have long plagued the laboratory industry putting patients at risk of 
transfusion-related death, medication errors, misdiagnosis, and patient mismanagement. It 
has been estimated over 160,000 adverse patient events occur each year in the U.S. because 
of patient or specimen identification errors involving the laboratory.1 Eleven percent of all 
transfusion deaths occur as a result of the phlebotomist not properly identifying the patient 
or mislabeling the tube of blood.2 Inadequately labeled samples account for 5.6–6.7% of all 
rejected samples.3, 4 A 2009 Q-Probes study found the rate of tube mislabeling of blood 
bank samples to be 1.12 percent. 5
The use of barcoding systems for specimen labeling and point-of-care test barcoding was 
established by the Centers for Disease Control and Prevention (CDC) as a Best Practice in 
2010 to reduce identification errors and improve the accuracy of patient specimen and 
laboratory testing identification in hospital settings.6, 7 However, between 2007 and 2015 the 
incidence of wrong-blood-in-tube errors (WBIT) remained unchanged even though barcode 
scanner usage increased from eight percent to 38 percent during the same period.8
A thorough literature review and establishment of Best Practices for the industry are 
necessary to protect patients from the threats of specimen labeling errors. The objective of 
this review is to identify and evaluate the effectiveness of existing interventions /practices to 
develop evidence based recommendations for the best laboratory practices to reduce sample 
labeling errors.
DESCRIPTION OF EVALUATED PRACTICES
In this review we evaluated the effectiveness of four laboratory practices to reduce the 
specimen labeling errors at the time of specimen collection,
• Improved Communication and Collaboration between Laboratory and Healthcare 
Professionals: Formation of Multidisciplinary Teams
• Education and Training of healthcare staff responsible for specimen collection
• Audit and Feedback of Labeling Errors: Real time event reporting
• Implementation of new Technology
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Improved Communication and Collaboration between Laboratory and Healthcare 
Professionals: Formation of Multidisciplinary Teams (MDT)
MDT approach help to improve the communication and collaboration between the key 
stakeholders including pathologists, radiologists, diagnosticians, management, and treating 
health care professionals (clinicians and nurses) to reduce diagnostic errors related to patient 
misidentification due to labeling errors.9 Generally the improved collaboration in the form 
of MDT result into emphasize that health-care providers have primary responsibility for 
checking/verifying a patient’s identity, development of standardized organization policies 
and protocols to emphasize the importance of positive patient identification that are 
compatible with the values and needs of the medical facilities, e.g., requirement of unique 
patient identifiers on specimen labels, implementation of zero tolerance policy, staff 
performance assessment, availability of adequate number of qualified personnel to perform 
specimen collection, reinforcement of specimen labeling at the bed side, delta checks etc.
Education and Training of Healthcare Staff Responsible for Specimen Collection
These interventions include education and training of laboratory staff (e.g., technicians/
scientists, phlebotomists) and clinical staff (e.g., nurses) who are responsible for collection 
and labeling of patient specimen in clinical settings. Education and training sessions serve to 
maintain and increase the knowledge and skills of the staff that involve patient preparation, 
filling of test requisition form (TRF), collection and labeling of patient specimen.
Education and training can be conducted through different outreach methods, e.g., 
educational training modules, dissemination of information through seminars, bulletins, 
newsletter, courses, infographics, and technical briefs, training in phlebotomy practices, 
training in technology and practical demonstrations during training sessions.
Audit and Feedback of Labeling Errors: Real time event reporting
Collection of information/ error data about mislabeled specimens on regular basis and 
feedback to the management and the involved staff with the aim to eliminate these errors or 
minimize the relative risk of errors. Literature has shown that sharing trending data on 
mislabeled samples on regular basis to patient care areas can change phlebotomy practices 
and reduce specimen mislabeling.
METHODS
The standardized LMBP A-6 methods were used to conduct LMBP systematic reviews have 
been described elsewhere.6 For this review, a systematic review team was formed including 
review coordinator, data abstractors, CDC liaison, and the advisory group called Expert 
Panel Team comprised of experts with varied professional experience. (Supplemental 
Appendix A lists the members of Expert Panel team for this review). The systematic review 
team worked under the oversight of the independent, unpaid, nonfederal LMBP Workgroup 
team. (Supplemental Appendix B lists the LMBP Workgroup members).
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Ask (A-1): Review Question and Analytic Framework
Review Question (s)—What practices are effective at reducing patient identification (ID) 
errors due to specimen mislabeling at the time of sample collection in all types of healthcare 
settings?
To address the applicability of the implementation of evaluated interventions to reduce 
specimen labeling errors, we also investigated whether the effectiveness of these practices 
vary according to the,
• Type of setting/ population (e.g., emergency, in-patient, out-patient)
• Organization type (e.g., academic institution, private clinic)
The conceptual approach in Figure 1 illustrates the causal relationship of the laboratory 
interventions to the relevant intermediate outcomes, e.g., reduction in patient labeling errors 
and associated harm to patient health due to missed/ delayed diagnosis, unnecessary blood 
draws, wrong treatment and improved patient satisfaction by a decrease in treatment delay, 
hospital stay, and related costs. Ultimately, these interventions may lead to decrease in 
overall morbidity and mortality and decrease in healthcare costs at organizational level.
Following PICO elements were considered for this review:
Population—General patients attending all types of healthcare settings who require 
specimen collection for diagnostic laboratory testing.
Intervention—Following practices to reduce patient identification due to labeling errors 
were evaluated
• Improved Communication and Collaboration between Laboratory and Healthcare 
Professionals: Formation of Multidisciplinary Teams
• Education and Training of healthcare staff responsible for specimen collection
• Audit and Feedback of Labeling Errors: Real time event reporting
• Implementation of new Technology (other than barcoding): e.g., automatic 
identification and data capture (AIDC) systems include radio frequency 
identification (RFID), biometrics (e.g., optical character recognition), magnetic 
stripes, smart cards, point-of-care label printers and scanners, voice recognition.
Comparison group—Group with no exposure to the intervention/practice of interest
Outcomes of interest
Primary outcome(s) of interest
• Decrease in specimen labeling errors at the time of specimen collection
• Decrease in patient harm due to,
– Misdiagnosis
– Unnecessary blood draws
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– Wrong treatment
• Increase in patient satisfaction by decrease in,
– Treatment delay
– Hospital stay
– Related cost
• Decreased specimen rejection rate
Long term Healthcare outcomes: Decrease in related,
• Morbidity and Mortality
• Overall Healthcare costs
There is no generally accepted taxonomy of identification errors. Varied definitions for 
‘specimen mislabeling’ have been used interchangeably in the existing literature. For 
example, when a specimen from one patient is labeled with another patient’s name some 
studies described this error as ‘mislabeled specimens’ when as others categories this error as 
‘wrong blood in tube’. For the analyses purposes, we lumped subsequent categories as 
‘specimen labeling errors’ in this review and each category was defined as follows,
Mislabeled/ misidentified specimen—Specimen label with patent identifiers from 
wrong patient, mostly referred as wrong blood in tube (WBIT) in the literature.
Mismatched labels—Patient information on the label does not meet with the 
accompanying requisition form or patient information on specimen label does not match 
with the patient’s wrist band
Incomplete, illegible or unlabeled specimen label—A specimen with a label that 
lists only partial information of required unique patient identifier; a specimen without a label 
or without any patient identifiers on the label; and finally specimen label that had illegible 
patient identifiers that could be read electronically or manually respectively.
Inclusion /Exclusion Criteria for Evidence to be Included in this Review
Exclusion Criteria: To be included in this review the study had to
• evaluate the effectiveness of at least one of the interventions/ practices of interest 
to reduce specimen labeling error;
• report at least one of the outcomes of interest (listed above) after the intervention 
implementation;
• be primary research published in an English-language journal, or available as a 
dissertation or a technical or government report;
• employ a study design that compared outcomes of interest with and without the 
new practice implementation to reduce specimen mislabeling e.g., pre- and post- 
intervention data, concurrent comparison data such as RCTs. In addition, this 
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review included labeling errors associated with all types of patient specimens 
collected from the patients for laboratory diagnostic testing (e.g., blood, urine, 
CSF, sputum).
Exclusion Criteria: The studies on the effectiveness of barcoding practices for reducing 
patient specimen and laboratory testing identification errors were excluded from the 
‘Implementation of New Technology’ category as these practices are already evaluated in 
one of the previous LMBP reviews.7
Acquire (A-2): Search for Evidence
Published evidence was searched between the time periods of 1990 to September 2015 using 
the following databases: Medline OVID (R), Embase OVID, CINAHL EbscoHost, Cochrane 
Library Database, Dissertation Abstracts, and PubMed to identify studies relevant to 
evaluations of interventions to reduce specimen mislabeling. Search details are available at 
Supplemental Appendix C. In addition, the systematic review team retrieved evidence from 
other informal sources such as hand searches including relevant references from all retrieved 
articles and additional studies identified by subject matter experts on the e-SBI systematic 
review team were incorporated into the review. We also received relevant unpublished data 
from the researchers, laboratories, and institutions in the field through personal requests and 
LMBP™ website but none of the unpublished data qualified to be included in this review. A 
total of 10,854 relevant records (both published and unpublished) were retrieved as a result 
of formal and informal literature searches. (Figure 2)
Appraise (A-3): Screening, Data abstraction and Quality scoring of Individual Studies
Retrieved evidence was screened at different levels, e.g., title screening and abstract 
screening to identify studies meeting the inclusion criteria. The data was abstracted from 
each study that met the inclusion criteria by 2 reviewers using the Standardized LMBP™ 
abstraction methods and abstraction form. Any discrepancies among the reviewers were 
reconciled by consensus. Based on the abstracted data, each study was rated using a 10 point 
scale for study quality as good (8–10 score), fair (5–7 score), or poor (≤4 score). Details for 
the LMBP quality scoring process can be found elsewhere.10 Studies with good and fair 
quality of execution were included in this review analysis. Supplemental Appendix D 
describes the Evidence Summary Tables containing detail information and quality ratings for 
each study.
Analyze (A-4): Summarization of results and strength of the Effect Magnitude
Effect estimates for each practice effectiveness were calculated as relative percentage point 
change (pct pt) where the studies reported the percent change in specimen labeling errors 
due to the intervention implementation. For each study, the effect estimates were calculated 
separately using the last available data point.
Following formula was used to calculate the relative percentage change in labeling errors:
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Where the Intervention Pre and Intervention Post represent the percent of labeling errors 
before and after the intervention implementation respectively.
The effect size strength rating for each individual study was based on the range of 
percentage change in labeling errors due to the intervention, the reduction in labeling errors 
between 0% to ≤ 40% was considered ‘minimal’ magnitude of effect; any decrease in 
labeling errors between >40% to ≤ 75% was considered ‘moderate’ magnitude and finally 
any decrease in labeling errors > 75% was considered ‘substantial’ magnitude of effect.
LMBP criteria were used to make conclusions on the overall strength of evidence on 
effectiveness which is based on the total body of evidence by taking into account the number 
of studies included in the evidence, quality of available evidence, consistency of results, 
magnitude of effect estimates, and applicability considerations. More details about these 
criteria can be found elsewhere.6
RESULTS
From the broader search for evidence, a total of 10,854 references were retrieved. After 
removing 167 duplicates and 10,567 off the topic, 66 were considered for full abstraction. 
After the full abstraction and quality scoring, eleven studies were qualified to be included in 
the systematic review. (Figure 2) Majority of the studies were conducted in USA11–20, one 
in India21 and one in Spain.22
Practice 1: Improved Communication and Collaboration between Laboratory and 
Healthcare Professionals: Formation of Multidisciplinary Teams
Seven studies11, 15–20 were identified to be included in the analyses to investigate the 
effectiveness of interventions that were developed and implemented due to the improved 
communication and collaboration between clinical staff and laboratory personnel. 
Three18–20 studies were of ‘good’ quality and four studies11, 15–17 were of ‘fair’ quality. All 
identified interventions for this category comprised of formation of multidisciplinary teams 
including the representatives from diverse disciplines (e.g., testing laboratory personnel, 
clinicians, nurses or other healthcare professionals). The teams met on regular basis to 
develop collaborative approaches according to the organizational needs that were acceptable 
and sustainable to staff in order to reduce specimen identification errors. The interventions 
were targeted to the general population in five studies15–18, 20, children and adults in one 
study,19 and in one study the target population was newborn children.11 The total evidence 
was derived from varied types of healthcare settings, i.e., three studies15–17 were conducted 
in entire facilities including different settings such as inpatient, ambulatory, surgical services 
areas, emergency department, ICU, general care unit, one study19 in inpatient setting, one20 
in surgical unit, one18 in dermatology unit, and one11 in pediatric department.
Four studies15, 18–20 measured the effect of standardized specimen labeling policies 
developed as a result of multidisciplinary approach that required inclusion of specific patient 
identifiers in specimen labeling (e.g., patient full legal name, DOB, Date and time of 
collection, initials of person collecting the specimen) and also educated staff about those 
standardized policies. Three studies18–20 implemented policies that required to print 
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specimen labels at the time of specimen labeling process and use of one sheet for blood and 
other bodily fluid specimens from the same patient.
The overall findings from the combined data from seven studies11, 15–20 found that the 
interventions developed as a result of improved communication and collaboration between 
the laboratory and clinical staff resulted in substantial decrease in specimen labeling errors 
(Median relative percent change in labeling errors: −75.86; IQI: −84.77, −58.00). (Figure 3). 
Results from all studies were statistically significant but for one study17 due to the limited 
information available to calculate the significance of results. The strength of the effect size 
was considered ‘substantial’ from four studies11, 15, 17, 19 ‘moderate’ from two studies, 16, 20 
and ‘minimal’ for one study18. Overall data showed that improved communication and 
collaborative efforts by the clinical and laboratory staff (e.g., development of standardized 
policies and practices for specimen labeling and organizational workflow chart to determine 
strategies to check for any scope of errors, establishment of processes to check specimen 
slips for missing collection dates) resulted in significant decrease in the rate of specimen 
identification errors.
In addition, the results from the sub-analyses performed for four studies15, 18–20 showed a 
‘moderate’ decline in specimen labeling errors after the institution of the standardized 
specimen labeling policy, i.e., inclusion of unique patient identifiers on the specimen 
labeling. (Median relative percent decrease in specimen labeling errors: −72.45; IQI: −83.25, 
−46.50). The results from all these studies were statistically significant and were 
consistently in a favorable direction. (Figure 4).
Conclusions—Applying the LMBP™ criteria, the overall strength of evidence from seven 
studies11, 15–20 is considered ‘sufficient’ to recommend that the improved communication 
and collaboration between laboratory and healthcare professionals by forming 
multidisciplinary teams is effective to decrease the specimen identification errors. (Table 1) 
Based on sub- group analysis, there was sufficient evidence of ‘moderate’ strength’ (based 
on four studies)15, 18–20 to recommend that the implementation standardized policies that 
require specific patient identifiers on specimen label developed by collaborative efforts 
between laboratory and healthcare staff are effective in decreasing specimen labeling in 
healthcare settings. (Table 2)
Practice 2: Education and Training
Two studies13, 21 were identified that evaluated the effectiveness of education and training 
interventions to decrease the specimen labeling errors. One study21 was good quality and 
one13 was of fair quality. Results from one study21 showed substantial reduction in patients 
with wrong identification due to the labeling errors. (Relative percent change: −90.89; IQI: 
−97.86, −61.14) after introducing training and education sessions for medical, nursing, and 
laboratory staff as part of the continuous medical education. Another study13 showed 
minimal decrease in the specimen labeling after the nursing in-service education over the 
period of six months along with the provision of 24-hour phlebotomy services at the facility. 
(Relative percent change: −35.77; IQI: −51.58, −14.80). (Figure 5)
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Conclusions—Both included studies showed a consistent decrease in sampling errors, 
however due to the small number of studies, according to the LMBP rules,6 evidence is 
considered ‘insufficient’ to determine if education and training interventions are effective in 
reducing patient misidentification due to the labeling errors. (Table 3)
Practice 3: Audit and Feedback
Three studies12, 13, 22 were included in the analyses to investigate the effectiveness of audit 
and feedback interventions. One study22 was of ‘good’ quality and two12, 13 studies were of 
‘fair’ quality of execution. Two studies12, 13 were conducted in the USA and one study in 
Spain. 22 The interventions in the included studies involved reporting or feedback of 
specimen mislabeling data from the laboratories to the management and the staff responsible 
for specimen collection and labeling on a regular basis. The combined results from three 
studies showed that after the intervention implementation there was a significant decrease in 
labeling errors (Overall decrease in median relative percent change in labeling errors: −58.0; 
IQI: −74.77, −30.08). Results from the two studies13, 22 were statistically significant and 
from one study12 were not statistically significant. (Figure 6) The effect size from two 
studies12, 13 was of ‘moderate’ strength and from one study22 was of ‘minimal’ strength. 
(Table 4)
Conclusions—Applying the LMBP™ criteria, the overall strength of evidence is 
considered ‘insufficient’ due to small number of included studies and weak effect size to 
draw any conclusions on the effectiveness of ‘audit and feedback’ interventions at reducing 
errors related to specimen labeling in all types of clinical settings. (Table 4)
Practice 4: Implementation of new Technology
No study qualified to be included in the analyses to evaluate the effectiveness this 
intervention category.
DISCUSSION
Best practices recommendations
Based on the findings from the included evidence, the interventions involving improved 
communication and collaboration between laboratory and healthcare professionals by 
forming multidisciplinary teams are recommended to decrease the specimen identification 
errors.11, 15–20
Particularly, the development and implementation of standardized policies and strategies 
(e.g., use at least two identifiers to verify a specimen/patient identity on the specimen label) 
by the MD teams at organizational level.15, 18–20 The findings from this review showed that 
other evaluated practices, i.e., training and education of the specimen collection staff, audit 
and feedback of labeling errors also led to decrease in specimen labeling errors. However, 
due to insufficient available evidence no recommendations could be made, ‘in favor or 
against’, the effectiveness of those practices.
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In laboratory medicine, correct linking of the specimen to the patient from whom it was 
collected is identified as an essential and fundamental objective for improving patient health 
and safety as it impacts on all aspects of patient care including correct diagnosis and right 
treatment. In 2013, Joint Commission identified accurate specimen/ patient identification as 
first of the National Patient Safety Goals, and this continues to be an accredited 
requirement .23 The World Health Organization (WHO) considers identification a priority 
area for improving patient safety, recommends for staff education and training to ensure 
correct specimen/patient identification among all healthcare organizations. 24 Various 
approaches have been proved to be effective to improve specimen labeling errors when 
implemented among different facilities within a health-care system. Evidence showed that 
education and training programs for the staff responsible for specimen collection and 
labeling 22, 25, 26 and audit/continuous monitoring and reporting of specimen labeling 27 
have been proved to reduce specimen/patient identification error. 27–29
The findings from our review appear to be similar to a recent systematic review that 
addressed the errors related to the wrong blood in tube (WBIT) and investigated what 
interventions (single or multiple) were successful in reducing WBIT. This review found that 
the interventions including standardized labeling policies, staff education, weekly feedback, 
and electronic transfusion systems were likely to be more effective when implemented in 
combination than when implemented individually.30 However, most of the evidence came 
from the studies that implemented multiple practices at the same time and did not make an 
attempt to investigate the weighing of effectiveness of individual practice in relation to the 
other.
In this review we were able to measure the effectiveness of four individual practices to 
reduce the specimen labeling errors at the time of specimen collection.
CONSIDERATIONS FOR IMPLEMENTATION
Lack of knowledge and training of non-laboratory staff (e.g., doctors and nurses) regarding 
specimen collection procedures like phlebotomy may contribute to pre analytical errors 
including specimen mislabeling. Educational and training interventions targeting non-
laboratory staff can be more effective to improve specimen mislabeling.13, 19, 31 Other 
factors contributing to labeling errors are identified as lack of compliance by the staff to the 
specimen labeling SOPs majority of the times due to the short cuts and workarounds 32, 
furthermore staff turnover is a major issue in lab and nursing. 33 To mitigate these barriers 
incorporating staff training sessions into their orientation as well as routine continuing 
ongoing professional development sessions may prove to be more effective vs. one time 
training. Annual competency checks for new as well as existing employee(s) is required. 
Finally it is also suggested that patient involvement can play an important role to improve 
their own identification. Therefore, interventions that encourage patient and family 
involvement to verify and confirm patient information should not be undervalued in order to 
reduce patient identification errors. 24
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ECONOMIC EVALUATION
No eligible economic evaluations were identified for analysis of cost-effectiveness.
POTENTIAL HARMS
Some of the interventions to reduce specimen labeling errors may have unintended 
disadvantages. Interventions may result in increased cost of operations due to 
implementation and maintenance of staff education and training. There can be additional 
cost associated with acquiring technical solutions and the training of the staff about the use 
of new technology. In addition, regular educational/trainings sessions may result in increase 
in staff workload and time spent away from the patients. Health care providers perceive that 
by repeated verification of patient identity may compromise their relationship with the 
patients.
STUDY LIMITATIONS AND FUTURE RESEARCH NEEDS
Due to the limited available evidence, no recommendations- ‘for or against’, the 
effectiveness the effectiveness of three evaluated practices could be made, i.e. interventions 
including education and training,13, 21 audit and feedback12, 13, 22 and implementation of 
new technology. More research is needed to evaluate these interventions to reduce specimen 
labeling errors.
Study design limitations regarding the entire evidence driven from before-and-after study 
design studies. Because of the uncontrolled nature of this design, there may have been 
unmeasured factors that changed between study periods that account for or influence the 
study results. Future studies of stronger research designs (e.g., randomized control trials) 
would be valuable to clarify effectiveness of interventions to reduce patient misidentification 
due to the labeling errors.
In this review, implementation of policies and strategies for specimen labeling developed as 
a result of improved communication and collaboration between the laboratory, management, 
and clinical staff remained effective for longer period (up to 3 years) of time. However, for 
other evaluated practices, i.e., staff education, audit and feedback interventions the follow-up 
period to report the results varied from 6 months to 1 year,12, 13, 21, 22 future research studies 
need to be conducted over a prolonged period required to examine the sustainability of the 
effects of these interventions for longer periods of time.
Large discrepancies in errors definitions, terminology, and error categorization strategies 
used in existing literature made it difficult to compare the studies. For example, the terms 
‘laboratory identification error’, ‘specimen identification error’, ‘patient identification error’, 
‘identification error’, ‘mislabeled specimen’, ‘unlabeled specimen’ have been 
interchangeably used for specimen labeling. Furthermore, use of variety of metrics/ 
measures for result reporting, such as percent change, change in error rate, error counts etc. 
made it challenging and difficult for synthesizing and summarizing findings from the total 
evidence. For future research it is warranted to use standardize term(s), definition(s) and 
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error detection methods and measures for result reporting in establishing future quality 
control studies to allow better analysis and better result interpretation.
In the majority of the existing literature, across the healthcare settings combination of 
interventions were implemented at the same time, e.g., staff training and education, labeling 
policies and processes to reduce the errors. It was difficult to disentangle what specific 
component attributed to the intervention effectiveness (e.g., do policy components or 
education components contribute more to intervention effectiveness; what are the central 
“active ingredients” in complex interventions). Providing more description information on 
how different best practices were implemented as an intervention to reduce errors might also 
help organizations replicate successes. The unpublished data that was retrieved from the 
laboratories was mostly trend data that did not qualify to be included in the final analyses, 
e.g., did not provide any comparison data to calculate the effect estimates. In routine, clinical 
laboratories study patient safety and quality improvement interventions, it is desired to 
design future quality improvement studies in such a way that the data driven from these 
studies can be utilized to demonstrate intervention effectiveness.
Finally, research showed that the incidence of specimen labeling errors vary according to the 
type of healthcare setting. For example the risk of these events is higher in the emergency 
departments due to rapid patient turnover, more interruptions to the medical staff in ED,32 
patients arrive unexpectedly who maybe unconscious or with no identification when 
compared to in patient setting where the patients are admitted for days for their treatment.33 
The findings from this review may not be generalizable across different type of healthcare 
settings due to limited data availability to investigate whether the recommended practices are 
equally effective in all types of settings (e.g., ED, pediatrics).
In summary, humans tend to cause errors and multiple corrective measures exist that focus 
on human factor improvement but the errors related to specimen labeling and patient 
identification continue to happen. Due to the potential adverse consequences on patient 
safety associated with mislabeled laboratory specimens, each and every specimen labeling 
error should be treated very seriously. Based on the findings from this review, multifaceted 
and multidisciplinary improvement approaches such as improved communication and 
collaboration between laboratory and healthcare professionals to develop and implement 
stringent and standardized specimen labeling policies and procedures can increase the 
patient safety by significantly reducing the incidence of specimen labeling errors at 
healthcare settings.
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Figure 1. 
Analytic Framework
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Figure 2. 
Patient Misidentification due to Specimen Labeling Errors Review Search Flow Diagram
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Figure 3. 
Improved communication and collaboration between laboratory and healthcare 
professionals: Formation of Multidisciplinary Teams
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Figure 4. 
Improved communication and collaboration between laboratory and healthcare 
professionals: Development of Standardized Policies and Practices
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Figure 5. 
Relative Percent Point Change in Specimen Labeling Erros Due To Educational and 
Training Interventions
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Figure 6. 
Relative Percent Point Change in Specimen Lebeling Errors Due Audit and Feedback 
Interventions
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Table 1
Improved Communication and Collaboration between Laboratory and Healthcare Professionals by Formation 
of Multidisciplinary Teams Interventions: Overall Practices
Studies (Published) Study Quality Rating Effect Size Rating
Zervakis, 2015 Good Moderate
Seferian, 2014 Good Substantial
Kim, 2013 Good Minimal
Rees, 2012 Fair Substantial
Pa Patient/ Shetterly, 2011 Fair Moderate
O’Neil, 2009 Fair Substantial
Foresberg, 1996 Fair Substantial
BODY OF EVIDENCE RATINGS 1 Good/ Substantial
1 Good/ Moderate
1 Good/ Minimal
1 Fair/ Moderate
3 Fair/ Substantial
CONSISTENCY Consistent
OVERALL STRENGTH Moderate
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Table 2
Improved Communication and Collaboration between Laboratory and Healthcare Professionals by Formation 
of Multidisciplinary Teams Interventions: Specimen labeling Policies and Processes
Studies (Published) Study Quality Rating Effect Size Rating
Zervakis, 2015 Good Moderate
Seferian, 2014 Good Substantial
Kim, 2013 Good Minimal
O’Neil, 2009 Fair Substantial
BODY OF EVIDENCE RATINGS 1 Good/ Substantial
1 Good/ Moderate
1 Good/ Minimal
1 Fair/ Substantial
CONSISTENCY Consistent
OVERALL STRENGTH Moderate
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Table 3
Body of Evidence LMBPTM Ratings for Educational and Training Interventions
Studies (Published) Study Quality
Rating
Effect Size Rating
Agarwal, 2012 Good Substantial
Wagar, 2006 Fair Minimal
BODY OF EVIDENCE RATINGS 1 Fair/ Moderate
1 Good/
CONSISTENCY OF RESULTS Consistent
OVERALL STRENGTH Insufficient
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Table 4
Body of Evidence LMBPTM Ratings for Educational and Training Interventions
Studies (Published) Study Quality Rating Effect Size Rating
Gonzalez-Porras JR, 2008 Good Minimal
Quillen and Murphy, 2006 Fair Moderate
Wagar, 2006 Fair Moderate
BODY OF EVIDENCE RATINGS 2 Fair/ Moderate
1 Good/ Minimal
CONSISTENCY Consistent
OVERALL STRENGTH Insufficient
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